Bioasis Technologies Inc. V.BTI

The Biodexa Presentation for Roadshows

[JDavenport]

Our Bioasis wife announced only yesterday that she was splitting up with us and the new guy has already moved in.

 

Take a look at the new and not improved corporate presentation on the Biodexis, I mean, Bioasis website.

 

30 pages and very little about xB3. Lots about EGF and Midatech's stuff, but only one xB3 program, Hunter syndrome. I cannot bring myself to believe that this bunch has plans for xB3 other than to take it private.

 

As I have expressed many times, I'm very sceptical of Bioasis's Hunter syndrome play. Denali is way ahead of Bioasis and JCR Pharmaceuticals of Japan already has theirs approved in Japan and is on the way to approval here. I've always suspected it's one of Chiesi's LSDs, held in storage so that one of Chiesi's 4 secret LSDs wasn't revealed by removing xB3-008 from the pipeline when the Chiesi deal was announced.

 

There are only a title page and two other pages about xB3 in this new presentation. If xB3 works, it could be worth billions and they all know it, and yet its potential value is not being promoted to sell this deal to anybody.

 

It's like, oh, yeah, this xB3 thing comes free with the deal. They're downplaying xB3. It's an absolutely awful feeling after all this time. Oh, but Biodexa will have xB3 programs! Yeah, sure, little ones.

 

There is no mention in the presentation about xB3-001 (Herceptin), xB3-004 (IL1-Ra), progranulin, or any of the other programs that Bioasis used to tout.

 

I told you all that Bioasis was underplaying xB3. For the last year I've been telling you that.

 

By the way, on page 7, the Bioasis deals are "detailed." Prothena is included. I don't really think that Prothena has much going on, maybe nothing. And as we know, they let their options go. And yet, the folks who put this presentation together say that the Prothena deal has the potential to bring in up to $30 million in proceeds. That was the original deal with a main target and 3 optional targets. The $30 million was spread around through all 4 of those targets. Those optional targets are gone. They expired on July 31, last year.

 

This corporate presentation is half baked, then fried, rolled in sugar, and dipped in gravy. It's bad for your health.

 

And yet I'm sure there is more to discover about it. 

 

Does anybody sense that the BoD and Dr. Deborah Rathjen are abrogating their fiduciary duties with this deal?

 

Where is xB3??

 

If they don't want it, can some of us put together a little group and buy it?

 

Nope. They have big plans for xB3.

 

jd

[JDavenport]

By the way, this new corporate presentation looks, to me, exactly like the one handed out at the roadshows, which somebody sent me. So you haven't missed much if you missed the roadshows. This deal is so bad that it's a wonder that Dr. Deborah Rathjen's reputagtion isn't worrying her.  One should never attribute to malice that which one can attribute to ignorance. So they

[prophetoffactz]

Looks like thy are going to ditch the name xB3; at least the presentation says they will rename Hunter BDX-008.

[JDavenport]

It wouldn't make sense, pof, for Biodexa to use the xB3 name for anything if they're going to sell the xB3 program off. I believe that's what this play is all about, to get xB3 into other hands for next to nothing. jd

[Georgeparros]

Does anybody sense that the BoD and Dr. Deborah Rathjen are abrogating their fiduciary duties with this deal? Yes, lets sue?

[ronrydell]

Absolutely....we need a group that will first pay for an injunction...so they can't close...then call for all the written transcripts via a subpoena to examine what happened here...The investment is getting an egregious fee out of this and the CEO saved herself over us....we need followthru on this post. I'm good for $5000 alone with at least 10 others and we'll escrow the money and

[JDavenport]

You may need a few million, ronrydell, to pay off Lind and the other debt holders, or risk losing the Bioasis IP.if the debts default. I mean, that was part of the set up. It looks like Ladenburg Thalmann are experts at this sort of thing. We all can understand people like those at Ladenburg Thallmann. They make movies about people like that. What you don't expect is for your own CEO to side

[ronrydell]

This merger agreement will NOT stand if it's determined that it was/is a criminal act...A firm cannot rape shareholders like this...read the NR...it's unbelievable!

[Aarcor]

Incredible that the dupes on his board can't figure out anything. Rathjen is a horrendous, incompetent business manager. A complete failure.  I've been saying that for 2+ years as JD, the 7 simps, and guys like Kayaker were telling me I was just a whiner.  Now it's like they all knew it all along.  Sheesh. Despite how worthless Rathjen is, it's obvious this is no

[JDavenport]

Rathjen is not worthless or imcompetent, Aarcor She set this up in the dark. She executed it in the dark with careful and minimal disclosures. She'll make a lot of money from it. I have lots of words to describe her but worthless and incompetent aren't at the top of the list. About you predicting and characerizing a deal of this sort, you most certainly did not. Don't bother